Cargando…
阿来替尼治疗ALK阳性非小细胞肺癌：1例报告及文献复习
Lung cancer is a malignant tumor with high incidence rate and mortality rate in China and even the whole world, of which non-small cell lung cancer accounts for about 80%. Anaplastic lymphoma kinase (ALK) gene mutation accounts for about 5%. Alectinib, ALK-tyrosine kinase inhibitor (ALK-TKI), has gr...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503986/ https://www.ncbi.nlm.nih.gov/pubmed/34521190 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.101.34 |